Enveric Biosciences Inc vs Plug Power Inc — how do they compare? Enveric Biosciences Inc trades at $1.51 (market cap $6.80M), while Plug Power Inc trades at $1.75 (market cap $2.42B). The key difference: Plug Power Inc is far larger — about 355.9× Enveric Biosciences Inc's market cap, and Enveric Biosciences Inc is more actively traded (64,867 versus 53,851,702). Which is the better fit depends on your goals — on Pluang, investors hold Enveric Biosciences Inc for 14 Days and Plug Power Inc for 41 Days on average.
| ENVB | PLUG | |
|---|---|---|
Market Cap | $6.80M | $2.42B |
Volume | 64,867 | 53,851,702 |
Sector | Health | Industrials |
52-Week High | $10.80 | $4.14 |
52-Week Low | $1.27 | $1.73 |
Typical Hold Time | 14 Days | 41 Days |
Enterprise Value | -$1.49M | $3.29B |
Signals from Pluang's Aura AI — not financial advice
ENVB trades at $1.495 with a 1.7% daily gain, showing technical bearish signals despite recent earnings beats. The company reported no revenue in 2025 with significant losses (-$8.77M net income), though valuation metrics appear low (EV/EBITDA 0.17, P/B 0.84). Recent news highlights patent approvals and positive preclinical data for non-hallucinogenic therapeutics.
The outlook remains speculative given the lack of revenue and substantial losses, offset by strong analyst support (75% buy rating) and promising drug development progress. Key risks include funding needs and clinical trial outcomes, while institutional sentiment appears cautiously optimistic about long-term pipeline potential.
Plug Power (PLUG) trades at $1.78, down 4.3% today, reflecting ongoing operational challenges despite recent strategic partnerships. The stock shows bearish technical signals with negative moving averages, while fundamentally the company continues to report significant losses with a -220.59% net income margin and negative cash flow. Recent news highlights a major 280 MW electrolyzer agreement with Arcadia eFuels and expansion in Australia/New Zealand, providing potential growth catalysts amid persistent financial headwinds.
The outlook remains challenging with substantial execution risks, though analyst consensus suggests 75% upside to the $3.13 price target. Key risks include continued cash burn, high debt levels, and competitive pressure in the hydrogen sector. Investment appeal depends on successful commercialization of green hydrogen projects and path to profitability.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →Plug Power is building an end-to-end green hydrogen ecosystem—from production, storage and delivery to energy generation. The company plans to build and operate green hydrogen highways across North America and Europe. Plug will deliver its green hydrogen solutions directly to its customers and through joint venture partners into multiple end markets—including material handling, e-mobility, power generation, and industrial applications.
Read more on PLUG →